These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21797823)

  • 21. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and development of mPGES-1 inhibitors: where we are at?
    Chang HH; Meuillet EJ
    Future Med Chem; 2011 Nov; 3(15):1909-34. PubMed ID: 22023034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E₂ synthase-1 enzyme (mPGES-1).
    Lauro G; Strocchia M; Terracciano S; Bruno I; Fischer K; Pergola C; Werz O; Riccio R; Bifulco G
    Eur J Med Chem; 2014 Jun; 80():407-15. PubMed ID: 24794772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1.
    Wu TY; Juteau H; Ducharme Y; Friesen RW; Guiral S; Dufresne L; Poirier H; Salem M; Riendeau D; Mancini J; Brideau C
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6978-82. PubMed ID: 20965723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation of a critical arginine in microsomal prostaglandin E synthase-1 shifts the isomerase activity to a reductase activity that converts prostaglandin H2 into prostaglandin F2alpha.
    Hammarberg T; Hamberg M; Wetterholm A; Hansson H; Samuelsson B; Haeggstro M JZ
    J Biol Chem; 2009 Jan; 284(1):301-305. PubMed ID: 18984580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886.
    Riendeau D; Aspiotis R; Ethier D; Gareau Y; Grimm EL; Guay J; Guiral S; Juteau H; Mancini JA; Méthot N; Rubin J; Friesen RW
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3352-5. PubMed ID: 15953724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1.
    Shang E; Wu Y; Liu P; Liu Y; Zhu W; Deng X; He C; He S; Li C; Lai L
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2764-7. PubMed ID: 24794107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel, non-acidic mPGES-1 inhibitors by virtual screening with a multistep protocol.
    Noha SM; Fischer K; Koeberle A; Garscha U; Werz O; Schuster D
    Bioorg Med Chem; 2015 Aug; 23(15):4839-4845. PubMed ID: 26088337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
    Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
    Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound design.
    Walker DP; Arhancet GB; Lu HF; Heasley SE; Metz S; Kablaoui NM; Franco FM; Hanau CE; Scholten JA; Springer JR; Fobian YM; Carter JS; Xing L; Yang S; Shaffer AF; Jerome GM; Baratta MT; Moore WM; Vazquez ML
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1120-6. PubMed ID: 23298810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
    Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexpression of microsomal prostaglandin E synthase with cyclooxygenase-2 in human rheumatoid synovial cells.
    Kojima F; Naraba H; Sasaki Y; Okamoto R; Koshino T; Kawai S
    J Rheumatol; 2002 Sep; 29(9):1836-42. PubMed ID: 12233875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
    Takeuchi C; Matsumoto Y; Kohyama K; Uematsu S; Akira S; Yamagata K; Takemiya T
    Neurochem Int; 2013 Feb; 62(3):271-80. PubMed ID: 23266396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics.
    Luz JG; Antonysamy S; Kuklish SL; Condon B; Lee MR; Allison D; Yu XP; Chandrasekhar S; Backer R; Zhang A; Russell M; Chang SS; Harvey A; Sloan AV; Fisher MJ
    J Med Chem; 2015 Jun; 58(11):4727-37. PubMed ID: 25961169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2.
    Sampey AV; Monrad S; Crofford LJ
    Arthritis Res Ther; 2005; 7(3):114-7. PubMed ID: 15899061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver X receptor ligands inhibit the lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 and diminish prostaglandin E2 production in murine peritoneal macrophages.
    Ninomiya Y; Yasuda T; Kawamoto M; Yuge O; Okazaki Y
    J Steroid Biochem Mol Biol; 2007 Jan; 103(1):44-50. PubMed ID: 17049841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes.
    Li X; Afif H; Cheng S; Martel-Pelletier J; Pelletier JP; Ranger P; Fahmi H
    J Rheumatol; 2005 May; 32(5):887-95. PubMed ID: 15868626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane prostaglandin E synthase-1: a novel therapeutic target.
    Samuelsson B; Morgenstern R; Jakobsson PJ
    Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of early growth response gene 1 in the modulation of microsomal prostaglandin E synthase 1 by epigallocatechin gallate in A549 human pulmonary epithelial cells.
    Moon Y; Lee M; Yang H
    Biochem Pharmacol; 2007 Jan; 73(1):125-35. PubMed ID: 17014826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore modeling and virtual screening for novel acidic inhibitors of microsomal prostaglandin E₂ synthase-1 (mPGES-1).
    Waltenberger B; Wiechmann K; Bauer J; Markt P; Noha SM; Wolber G; Rollinger JM; Werz O; Schuster D; Stuppner H
    J Med Chem; 2011 May; 54(9):3163-74. PubMed ID: 21466167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.